@MarkC53916729 @ErvinBrent @GoldmanSachs https://t.co/STpdYvktxq Janssen began  REEF-1 Phase IIB trials of JNJ-3989 9 (count em) months ago. $JNJ is certainly not standing in place. ~Meanwhile, $AMGN AMG-890 observes how crucially important clinical trials may be productively managed. $ARWR